A detailed history of Ci Investments Inc. transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Ci Investments Inc. holds 3,067 shares of PCVX stock, worth $226,620. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,067
Previous 2,460 24.67%
Holding current value
$226,620
Previous $281,000 10.68%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$80.97 - $117.93 $49,148 - $71,583
607 Added 24.67%
3,067 $251,000
Q3 2024

Nov 12, 2024

BUY
$70.52 - $117.12 $159,586 - $265,042
2,263 Added 1148.73%
2,460 $281,000
Q2 2024

Aug 12, 2024

SELL
$60.06 - $78.77 $171,591 - $225,045
-2,857 Reduced 93.55%
197 $15,000
Q1 2024

May 13, 2024

BUY
$59.79 - $81.05 $182,598 - $247,526
3,054 New
3,054 $209,000

Others Institutions Holding PCVX

About Vaxcyte, Inc.


  • Ticker PCVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,315,100
  • Market Cap $4.38B
  • Description
  • Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...
More about PCVX
Track This Portfolio

Track Ci Investments Inc. Portfolio

Follow Ci Investments Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ci Investments Inc. with notifications on news.